EW vs PAR · P/E 47, rev $1.39B vs rev $350.0M
Edwards Lifesciences Corp (EW) versus PAR Technology Corporation (PAR) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
PAR Technology Corporation (PAR) is a software - application company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PAR revenue for 2024-12-31 was $350.0M. Net income was -$5.0M. Revenue was up 26.5% from 2023-12-31 to 2024-12-31. PAR currently screens at market cap $612.5M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PAR currently screens at market cap $612.5M.
Not investment advice. Open the EW and PAR stock pages for the full models.
Not investment advice.